Dr Jorg Taubel, CEO of Richmond Pharmacology commented saying:
“The opening of our new research facility is a sign of our continued commitment to working alongside the leading research hospitals and universities in the UK to deliver cutting-edge clinical research across vital disease areas.
“Richmond are committed to making a significant and meaningful contribution to the health of the UK’s population and ensuring a sustainable future for the NHS through supporting the development of life changing and innovative medicines”
I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.
- Anonymous
Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.
- Anonymous
Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.
- Anonymous
Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review
Read more ›Richmond Pharmacology is delighted to confirm an upcoming event alongside the Department of International Trade in
Read more ›Richmond Pharmacology’s London Bridge Unit is now officially an ILS Resuscitation Council Course Centre. The
Read more ›Richmond Pharmacology with support from the Department of International trade will be participating in an event to
View event ›
+44 (0) 20 7042 5800
